Unuvar Emin, Yildiz Ismail, Kilic Ayse, Toprak Sadik, Aslan Seyhan Selvi, Aydin Salih, Badur Selim, Oguz Fatma, Sidal Mujgan
Department of Pediatrics, Istanbul University, Istanbul Medical Faculty, Capa, TR-34390, Istanbul, Turkey.
Int J Pediatr Otorhinolaryngol. 2007 Aug;71(8):1277-85. doi: 10.1016/j.ijporl.2007.05.002. Epub 2007 Jun 11.
To determine the efficiency of drugs, which include antihistaminic-decongestant-acetaminophen agents versus only acetaminophen in symptomatic treatment of acute nasopharyngitis in children.
This clinical, randomized, controlled, single blind drug efficacy comparison research was conducted in 148 patients with acute nasopharyngitis between ages 2 and 12 years. After randomization, Group-1 consisted of cases (n: 86), which used OTC drugs [acetaminophen+diphenhydramine+pseudoephedrin] and Group-2 consisted of cases (n: 62), which used only acetaminophen. After receiving nasal swab for showing the viral etiology, symptoms were scored clinically on admission and then on 10 days follow-up period, and re-evaluated on the third and fifth days of the drug therapy with the same scoring scale. Any complications were noted during the 1-month follow-up period after taking the drugs.
The virus isolation rate in Group-1 was 27.9% and in Group-2 was 22.6%. At the first day of study, before medication, clinic scores of the groups did not show a significant difference (Group-1 1.7 versus Group-2 2.0). Clinic scores in both groups on the third (Group-1 4.0 versus Group-2 4.1) and fifth days of therapy (Group-1 1.7 versus Group-2 2.0) were not different either. Also, the complication rate was not different during the 1-month follow-up period (Group-1 2.3% versus Group-2 8.0%, p: 0.12). The family response for the drug satisfaction in both groups was similar and positive.
For relieving symptoms of acute nasopharyngitis in children, acetaminophen without any combination is as effective as OTC drugs containing acetaminophen, decongestant, and antihistaminics.
确定药物的疗效,这些药物包括抗组胺 - 减充血剂 - 对乙酰氨基酚制剂与仅使用对乙酰氨基酚在儿童急性鼻咽炎对症治疗中的疗效。
这项临床、随机、对照、单盲药物疗效对比研究在148例2至12岁的急性鼻咽炎患者中进行。随机分组后,第一组由使用非处方药[对乙酰氨基酚+苯海拉明+伪麻黄碱]的病例(n = 86)组成,第二组由仅使用对乙酰氨基酚的病例(n = 62)组成。在采集鼻拭子以显示病毒病因后,入院时及随后10天的随访期间对症状进行临床评分,并在药物治疗的第三天和第五天使用相同的评分量表进行重新评估。在服药后的1个月随访期内记录任何并发症。
第一组的病毒分离率为27.9%,第二组为22.6%。在研究的第一天,用药前,两组的临床评分无显著差异(第一组1.7分,第二组2.0分)。治疗第三天(第一组4.0分,第二组4.1分)和第五天(第一组1.7分,第二组2.0分)两组的临床评分也无差异。此外,在1个月的随访期内并发症发生率也无差异(第一组2.3%,第二组8.0%,p = 0.12)。两组家庭对药物满意度的反应相似且为阳性。
对于缓解儿童急性鼻咽炎的症状,单独使用对乙酰氨基酚与含有对乙酰氨基酚、减充血剂和抗组胺药的非处方药效果相同。